Fractyl Health (GUTS) Income towards Parent Company (2023 - 2026)

Fractyl Health (GUTS) reported Income towards Parent Company of -$20.2 million for Q1 2026, up 16.61% year-on-year from -$17.3 million in Q1 2025, and up 10.65% quarter-over-quarter from -$22.6 million in Q4 2025.

Fractyl Health (GUTS) has 4 years of Income towards Parent Company data on file, last reported at -$20.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Income towards Parent Company rose 16.61% year-over-year to -$20.2 million; the trailing twelve-month figure through Mar 2026 stood at -$91.2 million (up 2.09% YoY), and the FY2025 full-year result was -$95.3 million, down 6.59% from the prior year.
  • Income towards Parent Company for Q1 2026 stood at -$20.2 million, up from -$22.6 million in the prior quarter.
  • Across five years, Income towards Parent Company topped out at -$11.7 million in Q1 2023 and bottomed at -$25.9 million in Q2 2025.
  • A 4-year average of -$19.6 million and a median of -$21.6 million in 2024 frame the typical range for Income towards Parent Company.
  • Across the five-year window, Income towards Parent Company slumped 95.59% in 2024 and grew 16.61% in 2026, its largest moves.
  • Tracing GUTS's Income towards Parent Company over 4 years: stood at -$12.5 million in 2023, then slumped by 95.59% to -$24.5 million in 2024, then advanced by 7.54% to -$22.6 million in 2025, then rose by 10.65% to -$20.2 million in 2026.
  • According to Business Quant data, Income towards Parent Company over the past three periods registered -$20.2 million, -$22.6 million, and -$22.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 1,638,563.89 Bn 1,638,563.89 Bn -
2 Alterity Therapeutics 767,934.24 Bn 767,934.20 Bn -
3 Legend Biotech 2,937.00 Bn 2,936.10 Bn 242.10 Mn
4 Nanobiotix 2,226.01 Bn 2,225.95 Bn -
5 Akari Therapeutics 2,169.69 Bn 2,169.69 Bn -
6 Vertex Pharmaceuticals 110.41 Bn 103.16 Bn 2.59 Bn
7 Regeneron Pharmaceuticals 66.44 Bn 57.69 Bn 3.31 Bn
8 Evaxion A 65.44 Bn 65.42 Bn -
9 Alnylam Pharmaceuticals 39.53 Bn 36.52 Bn 959.66 Mn
10 Fractyl Health 19.24 Mn 19.24 Mn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 -20.23 Mn
Dec 31, 2025 -22.64 Mn
Sep 30, 2025 -22.53 Mn
Jun 30, 2025 -25.85 Mn
Mar 31, 2025 -24.26 Mn
Dec 31, 2024 -24.48 Mn
Sep 30, 2024 -22.85 Mn
Jun 30, 2024 -21.61 Mn
Mar 31, 2024 -20.44 Mn
Dec 31, 2023 -12.52 Mn
Sep 30, 2023 -13.65 Mn
Jun 30, 2023 -11.72 Mn
Mar 31, 2023 -11.69 Mn